What happened
Gregg Williams, a director of Vivani Medical, Inc. (NASDAQ: VANI), bought 118,434 shares of common stock. The open-market purchases added to a stake held mostly through other entities without bringing new cash into Vivani.
Williams, listed as a 10% owner, spent about $128,000 over two trading days. Most of the buying came on the second day, when Williams also paid more per share on average.
On Nov. 18, Williams bought 33,169 shares at a weighted average of $1.05. Individual trades that day ranged from $1.02 to $1.07 per share.
On Nov. 19, Williams bought 85,265 shares at a weighted average of $1.10. Individual trades that day ranged from $1.06 to $1.13 per share, rounded to the nearest cent.
Explain the financial terms
An open-market trade is a purchase or sale on an exchange at the market price, not a grant, option exercise or private deal.
Why it matters
The purchases were a small addition even when measured against only the indirect stake. They increased Williams's indirect holdings by 0.3% from the 36,992,865 shares held before the first purchase, OptimistFi calculates.
The purchases brought the indirect position to 37,111,299 shares, separate from the 4,799,200 shares Williams owned directly. Williams had voting and selling authority over both parts of the stake, which totaled 41,910,499 shares after the purchases.
The Gregg G. Williams 2006 Trust accounted for most of the indirect position, with 34,985,547 shares. Williams International Co. LLC held the next-largest indirect block, with 1,212,856 shares.
The rest of the indirect stake was split between the Sam B. Williams 1995 Generation-Skipping Trust, with 731,309 shares, and Sam Williams Family Investments LLC, with 181,587 shares.
OptimistFi has argued that Vivani's implants need to make chronic-drug delivery easier and more consistent before cash burn and dilution erode the upside. The purchases increase Williams's exposure to that outcome but leave the investment case unchanged.
What's next
At Vivani's next quarterly report, lower operating cash use than in the prior quarter would ease the funding pressure OptimistFi sees on implant development.
Explain the financial terms
A fiscal quarter is a three-month period in the company's reporting year.

